Evaluation of DNA damage in Type 2 diabetes mellitus patients with and without peripheral neuropathy: A study in South Indian population

Journal of Natural Science, Biology and Medicine

Volumn 6, Issue 1, 2015, Pages 80-84

  Prasad, Mukul ^a   Bronson, Stephen Charles ^b   Warrier, Tushar ^a   Badarinath, Agnihotram ^a   Rai, Shivam ^a   Baid, Kaushal ^a   Sitaraman, Sneha ^a   George, Alex ^a   Moses, Anand ^b   Saraswathy, Radha ^a   Vasuki, Ranganathan ^b   Shanmugam, Alagianambi ^b  

^a VIT UNIVERSITY   (India)

^b MADRAS MEDICAL COLLEGE   (India)

Author keywords

CBMN Cyt assay; diabetic neuropathy; DNA damage; nuclear aberrations; oxidative stress; Type 2 diabetes mellitus

Indexed keywords

EID: 84921466103     PISSN: 09769668     EISSN: 22297707     Source Type: Journal    
DOI: 10.4103/0976-9668.149096     Document Type: Article

References (14)

1. Buse JB, Polonsky KS, Burant CF. Type 2 Diabetes Mellitus. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, editors. Williams Textbook of Endocrinology, 12th ed. Philadelphia: Elsevier-Saunders; 2011. p. 1371-435.
2. Feldman EL, Vincent A. The prevalence, impact and multifactorial pathogenesis of diabetic peripheral neuropathy. Adv Stud Med 2004;4:S642-9.
3. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic Neuropathies: A statement by the American Diabetes Association. Diabetes Care 2005;28:956-62.
4. Viswanathan V, Madhavan S, Rajasekar S, Chamukuttan S, Ambady R. Urban-Rural Diff erences in the Prevalence of Foot Complications in South-Indian Diabetic Patients. Diabetes Care 2006;29:701-3.
5. Feldman EL. Oxidative stress and diabetic neuropathy: A new understanding of an old problem. J Clin Investig 2003;111:431-3.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20.
7. Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T. Oxidative DNA damage in diabetes mellitus: Its association with diabetic complications. Diabetologia 1999;42:995-8.
8. Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2007;2:1084-104.
9. Cinkilic N, Kiyici S, Celikler S, Vatan O, Oz Gul O, Tuncel E, et al. Evaluation of chromosome aberrations, sister chromatid exchange and micronuclei in patients with type-1 diabetes mellitus. Mutat Res 2009;676:1-4.
10. Pereira CS, Molz P, Palazzo RP, de Freitas TA, Maluf SW, Horta JA, et al. DNA damage and cytotoxicity in adult subjects with prediabetes. Mutat Res 2013;753:76-81.
11. Hungerford DA. Leukocytes cultured from small inocula of whole blood and the preparation of metaphase chromosomes by treatment with hypotonic KCl. Stain Technol 1965;40:333-8.
12. Carrano AV, Natarajan AT. Considerations for population monitoring using cytogenetic techniques. Mutat Res 1988;204:379-406.
13. Natarajan AT. Chromosome Aberrations: Past, present and future. Mutat Res 2002;504:3-16.
14. Welles RV. Diabetic polyneuropathy: A review of the need for early diagnosis and treatment. Guthrie J 2003;72:13-7.